1-6 of 6
John A. Liu Yin
Close
Sort by
Journal Articles

Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

Clinical Trials & Observations
John A. Liu Yin, Michelle A. O'Brien, Robert K. Hills, Sarah B. Daly, Keith Wheatley, Alan K. Burnett
Journal: Blood
Blood (2012) 120 (14): 2826–2835.
https://doi.org/10.1182/blood-2012-06-435669
Published: 2012
Includes: Supplemental data
Journal Articles

Stage IV adult sporadic Burkitt lymphoma/leukemia with complex bone marrow cytogenetics is associated with a very poor outcome

Eleni Tholouli, Simon Watt, Guy S. Lucas, John Burthem, John A. Liu Yin, Jim Cavet, Hayley Greenfield, John B. Houghton
Journal: Blood
Blood (2009) 114 (2): 485–486.
https://doi.org/10.1182/blood-2009-03-213231
Published: 2009
Journal Articles

Real-Time PCR Gene Expression Profiling of Microarray Gene Signatures in Acute Leukemia.

Ebrahim Sakhinia, PhD, Mahboubeh Farahangpour, BSc, John A. Liu Yin, MD, PhD, Gerard Brady, PhD, Judith A. Hoyland, PhD, Richard J. Byers, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4401.
https://doi.org/10.1182/blood.V104.11.4401.4401
Published: 2004
Journal Articles

Stimulation of autologous proliferative and cytotoxic T-cell responses by “leukemic dendritic cells” derived from blast cells in acute myeloid leukemia

Beth D. Harrison, Julie A. Adams, Mark Briggs, Michelle L. Brereton, John A. Liu Yin
Journal: Blood
Blood (2001) 97 (9): 2764–2771.
https://doi.org/10.1182/blood.V97.9.2764
Published: 2001
Journal Articles

A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia

Eric Archimbaud, Oliver G. Ottmann, John A. Liu Yin, Klaus Lechner, Herve Dombret, Miguel A. Sanz, Gerhard Heil, Pierre Fenaux, Wolfram Brugger, Alan Barge, Caroline O’Brien-Ewen, James Matcham, Dieter Hoelzer
Journal: Blood
Blood (1999) 94 (11): 3694–3701.
https://doi.org/10.1182/blood.V94.11.3694
Published: 1999
Journal Articles

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

Gerhard Heil, Dieter Hoelzer, Miguel A. Sanz, Klaus Lechner, John A. Liu Yin, Giuseppe Papa, Luc Noens, Jeff Szer, Arnold Ganser, Caroline O'Brien, James Matcham, Alan Barge
Journal: Blood
Blood (1997) 90 (12): 4710–4718.
https://doi.org/10.1182/blood.V90.12.4710
Published: 1997